A new version is available. Please download for the best experience!
Publication Date: January 2, 2026
Subject: Security Patch Deployment Notice for the AI Organ Regeneration Platform (AiD Regen)
1. Summary
ROKIT Healthcare identified a security vulnerability affecting a specific function of the AI Organ Regeneration Platform (AiD Regen) during internal security review activities. To date, no security incidents or malicious exploitation related to this issue have been observed.
The identified vulnerability may affect certain supporting system functions; however, it is not considered to pose a direct risk to patient safety or clinical decision-making. ROKIT Healthcare is preparing a security update to address this issue, which will be deployed in a phased manner.
2. Products Impacted
AiD Regen v2.0.1
3. Vulnerability Overview
The AI Organ Regeneration Platform (AiD Regen) is a software platform designed to support clinicians in treatment planning based on data captured and processed in clinical settings.
The identified vulnerability is limited to a supporting file-handling function within the platform and, under certain conditions, could affect normal system operation. At this time, no evidence of exploitation, unauthorized access, or patient impact associated with this issue has been identified.
4. Actions Taken by ROKIT Healthcare
ROKIT Healthcare is preparing a security update to remediate this vulnerability. The update is expected to be deployed within a maximum of 30 days.
Detailed information regarding the deployment schedule and update process will be provided in advance.
5. Recommended Actions & Contact
Regeneration Platform
Customers and healthcare providers may continue using the system as intended.
If any unusual system behavior is observed, please contact ROKIT Healthcare using the information below.
When the security update becomes available, please apply it in accordance with the provided instructions.
Contact Information
Department: AI SBU Cybersecurity Division
Email: itsupport@rokit.co.kr
ROKIT HEALTHCARE Inc.